Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
Hernandezine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
ABP18
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
Trichostatin A
Potential treatment - theoretical effect Natural product Antiviral Apr/10/2021
Cepharanthine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
S-8510
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
Naphthazarin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
Glycyrrhizic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
mAb 58
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
PF-00835231
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
Menadione
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021
Niclosamide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
COV2-2489
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021
Nb11‐59
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/04/2021
Salvianolic acid C
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/08/2021
Reduning
Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021
Curcumin
Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021
COV2-2676
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021